Concepts (69)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Sturge-Weber Syndrome | 1 | 2006 | 5 | 0.280 |
Why?
|
Cerebral Veins | 1 | 2006 | 6 | 0.280 |
Why?
|
Intracranial Arteriovenous Malformations | 1 | 2006 | 15 | 0.280 |
Why?
|
Hydrocephalus | 1 | 2006 | 40 | 0.270 |
Why?
|
Glaucoma | 1 | 2006 | 50 | 0.270 |
Why?
|
Stroke | 3 | 2021 | 2161 | 0.200 |
Why?
|
Carotid Artery, Internal, Dissection | 1 | 2020 | 9 | 0.190 |
Why?
|
Vertebral Artery Dissection | 1 | 2020 | 8 | 0.190 |
Why?
|
Basilar Artery | 1 | 2020 | 38 | 0.190 |
Why?
|
Urban Population | 1 | 2021 | 254 | 0.180 |
Why?
|
Time-to-Treatment | 1 | 2020 | 117 | 0.170 |
Why?
|
Ischemic Attack, Transient | 1 | 2020 | 167 | 0.170 |
Why?
|
Magnetic Resonance Angiography | 2 | 2013 | 181 | 0.170 |
Why?
|
Emergency Medical Services | 1 | 2021 | 225 | 0.160 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2020 | 373 | 0.160 |
Why?
|
Rural Population | 1 | 2021 | 397 | 0.150 |
Why?
|
Anticoagulants | 1 | 2020 | 356 | 0.150 |
Why?
|
Calpain | 2 | 2007 | 205 | 0.130 |
Why?
|
Hyperoxaluria, Primary | 1 | 2013 | 3 | 0.120 |
Why?
|
Intracranial Embolism | 1 | 2013 | 25 | 0.110 |
Why?
|
Axons | 2 | 2007 | 139 | 0.090 |
Why?
|
Melatonin | 1 | 2007 | 39 | 0.080 |
Why?
|
Cephalometry | 1 | 2006 | 19 | 0.070 |
Why?
|
Cranial Sinuses | 1 | 2006 | 11 | 0.070 |
Why?
|
Orbit | 1 | 2006 | 30 | 0.070 |
Why?
|
Cerebral Angiography | 1 | 2006 | 151 | 0.070 |
Why?
|
Neuroprotective Agents | 1 | 2007 | 317 | 0.060 |
Why?
|
Nerve Degeneration | 1 | 2005 | 134 | 0.060 |
Why?
|
Spinal Cord | 1 | 2005 | 244 | 0.060 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 1 | 2005 | 133 | 0.060 |
Why?
|
Spinal Cord Injuries | 1 | 2007 | 551 | 0.050 |
Why?
|
Apoptosis | 1 | 2007 | 1640 | 0.050 |
Why?
|
Comparative Effectiveness Research | 1 | 2020 | 36 | 0.050 |
Why?
|
American Heart Association | 1 | 2021 | 142 | 0.050 |
Why?
|
Time Factors | 3 | 2020 | 4655 | 0.050 |
Why?
|
Consensus | 1 | 2021 | 211 | 0.050 |
Why?
|
Neurons | 1 | 2005 | 881 | 0.040 |
Why?
|
Follow-Up Studies | 1 | 2006 | 3256 | 0.040 |
Why?
|
Drug Administration Schedule | 1 | 2020 | 567 | 0.040 |
Why?
|
Male | 5 | 2020 | 37281 | 0.040 |
Why?
|
Longitudinal Studies | 1 | 2020 | 1054 | 0.040 |
Why?
|
Registries | 1 | 2020 | 730 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 1 | 2006 | 2222 | 0.040 |
Why?
|
In Situ Nick-End Labeling | 2 | 2007 | 160 | 0.040 |
Why?
|
Child | 1 | 2006 | 6400 | 0.030 |
Why?
|
Humans | 4 | 2021 | 68525 | 0.030 |
Why?
|
Prospective Studies | 1 | 2020 | 3702 | 0.030 |
Why?
|
Calcium | 2 | 2007 | 929 | 0.030 |
Why?
|
Diagnosis, Differential | 1 | 2013 | 1139 | 0.020 |
Why?
|
Adult | 2 | 2020 | 21375 | 0.020 |
Why?
|
United States | 1 | 2021 | 7335 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2020 | 7028 | 0.020 |
Why?
|
Rats | 2 | 2007 | 5300 | 0.020 |
Why?
|
Caspase 3 | 1 | 2007 | 233 | 0.020 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2007 | 282 | 0.020 |
Why?
|
Central Nervous System Depressants | 1 | 2007 | 182 | 0.020 |
Why?
|
DNA Fragmentation | 1 | 2005 | 85 | 0.020 |
Why?
|
Rats, Inbred Lew | 1 | 2005 | 150 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2005 | 306 | 0.020 |
Why?
|
Aged | 1 | 2020 | 14842 | 0.020 |
Why?
|
Cell Death | 1 | 2005 | 329 | 0.020 |
Why?
|
Acute Disease | 1 | 2005 | 658 | 0.010 |
Why?
|
Up-Regulation | 1 | 2005 | 682 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2005 | 1039 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2007 | 2083 | 0.010 |
Why?
|
Middle Aged | 1 | 2020 | 21119 | 0.010 |
Why?
|
Inflammation | 1 | 2007 | 1030 | 0.010 |
Why?
|
Animals | 2 | 2007 | 20877 | 0.010 |
Why?
|
Female | 1 | 2020 | 38015 | 0.010 |
Why?
|